Amendment to Gemphire Therapeutics Inc. Amended and Restated 2015 Equity Incentive Plan
This amendment updates the Gemphire Therapeutics Inc. 2015 Equity Incentive Plan to increase the total number of shares of common stock available for issuance under the plan. The amendment was adopted by the Board of Directors on April 9, 2018, and approved by stockholders on May 22, 2018. All other terms of the plan remain unchanged, and the plan continues in effect as amended.
Exhibit 10.2
AMENDMENT
TO THE
GEMPHIRE THERAPEUTICS INC.
AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN
ADOPTED BY THE BOARD OF DIRECTORS: April 9, 2018
APPROVED BY THE STOCKHOLDERS: May 22, 2018
The Gemphire Therapeutics Inc. Amended and Restated 2015 Equity Incentive Plan (the “Plan”) is hereby amended in the following respects, effective from and after the date approved by the stockholders of Gemphire Therapeutics Inc. as set forth above, in accordance with Sections 2(b)(vi) and (vii) of the Plan. Following such effective date, any reference to the “Plan” shall mean the Plan, as amended hereby.
Section 3(a)(i) of the Plan is deleted in its entirety and replaced with the following sentence:
“Subject to Section 9(a) relating to Capitalization Adjustments, and Section 3(a)(ii) regarding the annual increase, the aggregate number of shares of Common Stock that may be issued pursuant to Stock Awards will not exceed the sum of (A) 3,115,077 new shares, plus (B) the number of shares that are Returning Shares, as such shares become available from time to time (the “Share Reserve”).
Except as specifically set forth herein, the terms of the Plan shall be and remain unchanged, and the Plan as amended shall remain in full force and effect.
